Product Name | Vonoprazan Fumarate | TAK-438 |
---|---|
CAS | 881681-01-2 |
Formula | C17H16FN3O2S· C4H4O4 |
MW | 461.46 | 345.39 (Free) |
Appearance | White to off-white powder |
Storage condition | 4°C, sealed storage, away from moisture and light |
Vonoprazan Fumarate, also known as TAK438, is a new medicine for treating acid-related diseases with a novel mechanism of action called potassium-competitive acid blockers (P-CABs) which competitively inhibits the binding of potassium ions to H+,K+-ATPase (also known as the proton pump) in the final step of gastric acid secretion in gastric parietal cells. TAKECAB provides a strong and sustained acid secretion inhibitory effect.
© Copyright 2015-2021 Chemleader Biomedical Co., Ltd. All Rights Reserved.
沪ICP备15046197号-4
沪公网安备31011502007856号
Designed by Kuanersoft